The technology:

In a path breaking technological advancement, Prof. Sunamura of Japan has developed a novel metabolomics based technology in which analysing polyamines in the saliva can help in the screening for the following five different types of cancer

The process of saliva collection is simple, painless and non-invasive.

This testing is available in 600 clinics all over Japan

Unlike testing the cancer-risk using DNA which remains the same throughout life, these polyamines keep dynamically changing in the body and the metabolomics approach to evaluate them in saliva helps monitor them which will be directly correlative to the cancer evolving in the body

List of publications on the technology Click here

Dr. Makoto Sunamura
Chief Consultant
Gastro-enterologist, Oizumi Chuo Clinic &
Visiting Faculty, Tokyo Medical University, Japan


For profile of Dr. Sunamura Click here